Premature menopause associated with risk of lower cognitive function

Article

Early menopause-whether natural or surgical-may be associated with negative effects on cognitive function that are not entirely offset by postmenopausal hormone therapy (HT), according to a new study in BJOG.

 

Early menopause-whether natural or surgical-may be associated with negative effects on cognitive function that are not entirely offset by postmenopausal hormone therapy (HT), according to a new study in BJOG.

French researchers at Hospital La Colombiere assessed 4868 women aged aged 65 and older. A multivariable-adjusted logistic regression model was used to determine the association between age at menopause, the type of menopause (surgical or natural), and the use of HT and later-life cognitive function. Main outcome measures were a clinical dementia diagnosis and performance on a cognitive test battery, which was performed at baseline and over 7 years.

Story: BRCA gene linked with early menopause

Menopause at or before age 40, whether from premature bilateral ovariectomy or premature ovarian failure, was associated with worse verbal fluency (odds ratio [OR] 1.56, 95% confidence interval [CI] 1.12–1.87, P = 0.004) and visual memory (OR 1.39, 95% CI 1.09–1.77, p = 0.007) in later life. Although at onset of premature menopause, HT appeared to be beneficial for later-life visual memory, it appeared to increase the risk of poor verbal fluency. The type of menopause had no significant association with cognitive function. Women who experienced premature menopause had a 30% higher risk of decline in psychomotor speed and global cognitive function over 7 years.

Given the association between premature menopause and cognitive decline irrespective of HT, the researchers concluded that potential effects on cognitive function should be included in the risk/benefit ratio for ovariectomies in younger patients.


 

 

To get weekly advice for today's Ob/Gyn, subscribe to the Contemporary Ob/Gyn Special Delivery.

Newsletter

Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.

Recent Videos
Navigating hormone therapy in high-risk menopause cases | Image Credit: © dhaj7-cepo.com.
Non-hormonal treatments offer relief for genitourinary syndrome of menopause | Image Credit: providers.uthscsa.edu.
Jill Liss, MD, MSCP, FACOG, associate clinical professor, OB/GYN, at the University of Colorado School of Medicine.
Elizabeth Gandee, APRN-CNP, highlights gaps in women's menopause knowledge | Image Credit: wexnermedical.osu.edu
Shayna Mancuso, DO, highlights the real impact of menopause | Image Credit: linkedin.com.
Jennifer Payne, MD, highlights how to help young women with perimenopause symptoms | Image Credit: uvahealth.com/findadoctor.
Worse menopause symptom burden reported in rural women | Image Credit: uwmedicine.org.
How fezolinetant advances non-hormonal treatment of hot flashes | Image Credit: medschool.cuanschutz.edu
Rossella Nappi, MD, discusses benefits of fezolinetant against vasomotor symptoms | Image Credit: imsociety.org
JoAnn Pinkerton discusses elinzanetant's crucial role in VMS therapy | Image Credit: uvahealth.com
Related Content
© 2025 MJH Life Sciences

All rights reserved.